glp 1 agonist schizophrenia GLP-1 Receptor Agonists Improve Metabolic Outcomes in Patients on Antipsychotics: JAMA Real Psychiatry: Should GLP-1 agonists
Description
The logistical problems could lead to even more time off the medications
No statistical methods were applied to predetermine the sample size for in vivo pharmacology experiments
Research use only products arent meant for humans
2019;35(7):e3168
Short-acting drugs primarily lower postprandial blood glucose levels by slowing gastric emptying, while long-acting GLP-1 RAs are more effective at reducing fasting blood glucose levels, mainly by promoting insulin secretion and inhibiting glucagon release
